Cite

HARVARD Citation

    Ellis, M. et al. (n.d.). Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice. Leukemia research. 39 (11), pp. 1154-1158. [Online]. 
  
Back to record